Skip to content

Network of Cancer Research

Reliable, unbiased and up to date information in cancer research

Network of Cancer Research

Reliable, unbiased and up to date information in cancer research

  • Home
  • About
    • Home
    • 2023
    • June
Cancer

GXF-111 is a BRD3 and BRD4-L PROTAC Degradation Molecule for Cancer Research

Louis Gilman June 29, 2023

PROTACs are bi-functional molecules, capable of concurrently binding to target proteins of interest and the subunits of E3 ligases, such as Cereblon, VHL, and MDM2, among others. In short, Cooperative…

Prostate Cancer

WWL0245 is a Potent and Selective BRD4 PROTAC for AR-Positive Prostate Cancer Research

Louis Gilman June 27, 2023

Proteolysis targeting chimeras (PROTAC) is a bifunctional molecule that could draw an E3 ubiquitin ligase close to a protein of interest (POI) and induce its degradation via the ubiquitin-proteasome system…

Cancer

Tipifarnib (IND 58359) is a potent FTase Inhibitor with Antineoplastic activity

Louis Gilman June 26, 2023

Farnesyltransferase (farnesyltransferase, FTase) is composed of the α subunit encoded by the FNTA gene and the β subunit encoded by the FNTB gene. FTase recognizes the C-terminal CAAX motif of…

Cancer

SRPIN803 is a CK2 and SRPK1 Dual Inhibitor for Age-related Macular Degeneration Research

Louis Gilman June 25, 2023

SRPIN803 can prevent VEGF production owing to the dual inhibition of SRPK1 and CK2. SRPKs are a critical enzyme family that regulates splicing activity in the cell. Serine-arginine protein kinase…

autoimmune disease Cancer Obesity

Rapamycin is a mTOR Inhibitor and Autophagy Activator for Cancer Research

Louis Gilman June 23, 2023

mTOR is the target of Rapamycin. In the early 1990s, genetic screens in budding yeast identified the TOR1 and TOR2 genes as mediators of the toxic effects of Rapamycin on…

Colon Cancer

A011 is a Potent ATM Inhibitor for Colon Cancer Research

Louis Gilman June 22, 2023

ATM (ataxia-telangiectasia mutated) is a serine/threonine protein kinase that is recruited and activated by DNA double-strand breaks. Importantly, In response to DSB, the ATM kinase undergoes autophosphorylation and subsequently phosphorylates…

Cancer Gastric Cancer

MY-943 is a potent Tubulin Polymerization/LSD1 inhibitor that can be used for Gastric Cancer Research

Louis Gilman June 21, 2023

MY-943 is a potent tubulin polymerization and LSD1 inhibitor with anticancer activity. Tubulin in molecular biology can refer either to the tubulin protein superfamily of globular proteins, or one of…

Lung Cancer

Elesclomol (STA-4783) is a Potent Copper Ionophore and Promotes Cuproptosis (Copper-dependent cell death)

Louis Gilman June 20, 2023

Cuproptosis is a unique type of cell death that is copper-dependent. Copper is a double-edged sword. On the one hand, it is an important enzyme cofactor. On the other hand,…

autoimmune disease B-cell malignancies

BGB-8035 is an Orally Active BTK Inhibitor for B-cell Malignancies and Immunology Research

Louis Gilman June 19, 2023

Bruton tyrosine kinase (BTK) is a non-receptor kinase that plays a crucial role in carcinogenic signaling. Meanwhile, it plays a central role in the signal transduction of B cell antigen…

Prostate Cancer

Tipifarnib (IND 58359) is an FTase Inhibitor for Prostate Cancer Research

Louis Gilman June 14, 2023

Ras proteins play a crucial role in tumor diseases. Farnesylation is an important post-translational modification of Ras proteins. Whereas, that determines the oncogenicity and membrane-binding properties of Ras. Meanwhile, Farnesyltransferase…

Posts navigation

1 2

Next Page »

Recent Posts

  • BI 7446 is a STING Agonist for Immuno-oncology Research
  • JNJ-38877605 is an Orally Active c-Met Inhibitor for Solid Tumour Research
  • OATD-02 is an Orally Active Arginase 1/2 Inhibitor for Melanoma Research
  • INCB086550 is an Orally Active PD-L1 Inhibitor for Multiple Cancers Research
  • Panobinostat is a HDAC Inhibitor for Multiple Myeloma Research

Archives

  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019

Categories

  • Abdominal Aortic Aneurysm
  • Acute Leukemia
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Adenoid Cystic Carcinoma
  • Adenomyosis
  • Adrenocortical carcinoma
  • Adult T-cell leukemia/lymphoma
  • Anti-angiogenic
  • anti-inflammatory
  • antioxidant
  • autoimmune disease
  • B-cell malignancies
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer
  • Cancer Metastases
  • Castration Resistant Prostate Cancer
  • ccRCC
  • Cervical Cancer
  • Cervix Cancer
  • Chemotherapy
  • Chemotherapy Side Effects
  • Cholangiocarcinoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Colon Adenocarcinoma
  • Colon Cancer
  • Colorectal Cancer
  • Colorectal Cancer
  • Endometrial Adenocarcinoma
  • Endometrial Cancer
  • ER+ Breast Cancer
  • Esophageal Squamous Cell Carcinoma
  • Esophagus Cancer
  • Ewing's Sarcoma
  • Fibrosarcoma
  • Follicular Lymphoma
  • Gastric Adenocarcinoma
  • Gastric Cancer
  • Gastrointestinal Stromal Tumor
  • Glioblastoma
  • Glioblastoma Multiforme
  • Gliocytoma
  • Glioma
  • Head & Neck Cancer
  • Head and Neck Cancer
  • Hematologic Neoplasms
  • Hematological Malignancies
  • Hepatocellular carcinoma
  • HER2+ Breast Cancer
  • Hodgkin Lymphoma
  • HPV
  • HSV-1
  • Idiopathic Pulmonary Fibrosis
  • Kaposi's Sarcoma
  • Kidney Cancer
  • Large B Cell Lymphoma
  • Large B-cell Lymphoma
  • Large Cell Lung Cancer
  • Leukemia
  • Liver Cancer
  • Lung Adenocarcinoma
  • Lung Cancer
  • Lymphoma
  • Malaria
  • Mantle Cell Lymphoma
  • Medullary Thyroid Carcinoma
  • Medulloblastoma
  • Medulloblastomas
  • Megakaryoblastic Leukemia
  • Melanoma
  • Mesothelioma
  • Metabolism
  • Metabolism-related diseases
  • Metastatic Castration-resistant Prostate Cancer
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myelodysplastic Syndrome
  • Myeloma
  • Nasopharyngeal Carcinoma
  • Neoplasms
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Neuropathy
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • NSCLC
  • NUT midline carcinoma
  • Obesity
  • Oesophageal Cancer
  • Oral Carcinoma
  • Osteosarcoma
  • Ovary Cancer
  • Pancreas Cancer
  • Pancreatic cancer
  • Pancreatic Ductal Adenocarcinoma
  • Ph+ ALL
  • Philadelphia-positive Leukemias
  • Plasmacytoma
  • Prostate Cancer
  • PROTAC
  • Renal Carcinoma
  • Sarcoma
  • Skin Cancer
  • Small Cell Lung Cancer
  • Soft Tissue Tumor
  • Solid Tumors
  • Squamous Carcinoma
  • T Acute Lymphoblastic Leukemia
  • T-cell Lymphoma
  • Thyroid Cancer
  • Triple-Negative Breast Cancer
  • uncategorized
  • Uterine Serous Carcinoma

You Missed

Breast Cancer

BI 7446 is a STING Agonist for Immuno-oncology Research

Gastric Cancer Obesity

JNJ-38877605 is an Orally Active c-Met Inhibitor for Solid Tumour Research

Multiple Myeloma Myeloma

OATD-02 is an Orally Active Arginase 1/2 Inhibitor for Melanoma Research

autoimmune disease

INCB086550 is an Orally Active PD-L1 Inhibitor for Multiple Cancers Research

Network of Cancer Research

Reliable, unbiased and up to date information in cancer research

Copyright © All rights reserved | Blogus by Themeansar.